Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining ...

Around one in seven adults in the United States have chronic kidney disease (CKD), a condition in which the kidneys become damaged and can’t work as efficiently. This allows waste products to build up ...

Doctors often use 'renal failure' and 'kidney failure' interchangeably, both signifying a critical loss of kidney function. While 'renal' stems from L ...

If the drug works in people, it could prevent kidney injury in high-risk populations, or potentially even treat other ...

Plans to Initiate Phase 2 Basket Study in Glomerular Kidney Diseases in 2Q24 CAMBRIDGE, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed clinical ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, Series B, venture-backed clinical development stage company focused on transforming the treatment of ...

Engages Former FDA Director of Division of Cardiology and Nephrology, Norman Stockbridge, M.D., Ph.D., to Advise on Walden’s Clinical Pipeline in Rare Kidney Diseases Utilizes Rare Kidney Disease ...

$54.5 million in seed financing led by founding investor 5AM Ventures alongside Atlas Venture, OrbiMed and Qiming Venture Partners USA Renasant Bio (Renasant), announced its launch today to advance ...

Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of ...